AI: All Hype, A Source of Hope, or Cause for Hesitation? Find out on the latest episode of the SNMMI Podcast! Now streaming wherever you get your podcasts. Listen here: www.buzzsprout.com/1986526/epis...

In celebration of the 85th World Theranostics Day, experts discuss what they want theranostics to achieve in their perfect world. What do you think we'll be celebrating by the next Theranostics Day? How about the one 10 years from now? In another 85? youtu.be/KFPwjK3YFmo

The Mars Shot Research Fund is pleased to announce that Kiran Solingapuram Sai, PhD has been selected as the recipient of the Steven Larson Named Lecture on Advanced Nuclear Medicine Research Award. Sai's grant was awarded based on his proposal, "Microtubule PET imaging in healthy older adults."

Should nuclear medicine be an independent department? We are uniquely positioned at the intersection of diagnostics and therapeutics, but every expert on this episode of the JNM Podcast had a different opinion about independence. Tune in to hear more: youtu.be/B7ku7m-t6bc

Next week, SNMMI will participate in a multi-stakeholder advocacy day alongside @AcadRad to advocate for investment in nuclear medicine, molecular imaging, and the medical imaging community as a whole. More from SNMMI President Jean-Luc Urbain below👇

The latest issue of JNMT is out, and this month, we're focusing on neuroimaging! This issue of JNMT will give you the tools to understand the innovations in neuroimaging, incorporate new techniques, and expand the role of molecular imaging in neurology. Read it now: tech.snmjournals.org/content/54/1

A new targeted #PET-CT tracer can detect treatment response in rheumatoid #arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research from 🇳🇱 @amsterdamumc.bsky.social, published by @snm-mi.bsky.social.

@auntminnie.bsky.social covers how the rise of radiopharmaceuticals and theranostics creates more opportunities for nuclear medicine technologists. Read here: www.auntminnie.com/clinical-new...

Cognitive decline may look the same on the outside, but the biology of limbic-predominant age-related TDP-43 encephalopathy (LATE) vs. Alzheimer’s is notoriously hard to diagnose. In JNM, researchers use a novel PET/MRI approach to identify LATE: jnm.snmjournals.org/content/earl...

Do pizza Fridays actually combat burnout? Probably not! On this episode of the JNMT Podcast, host Jessica Settle is joined by Jamie Warren, a technologist and career coach who shares her insights about identifying, managing, and overcoming burnout. Listen here: youtu.be/wH-KohjGgAE?...

Ken Herrmann to be Next Editor-in-Chief of The Journal of Nuclear Medicine You may recognize Ken from the many episodes of the JNM Podcast he's hosted. As editor, Ken hopes to keep that engagement going -- and more! Learn more here: snmmi.org/Web/News/Art...

Public awareness doesn’t grow on its own, it takes a collective voice. When you’re an SNMMI-TS member, you're ensuring NMTs are recognized for their expertise. Join SNMMI or renew your membership & explore how we support you, beyond VOICE credits. snmmi.org/Shared_Conte...

Beyond "one-size-fits-all": A new strategy that combines two types of #PET scans can guide personalized #radiotherapy for head and neck cancers, according to new research led by 🇸🇪 @stockholm-uni.bsky.social, published by @snm-mi.bsky.social. #HeadAndNeckCancer #PersonalizedMedicine

SNMMI-TS Webinar: YOU Can Create Disney Magic Too... Lessons in Leadership, Management, Culture and World Class Customer Service Register here: events.teams.microsoft.com/event/0a5ee0...

SNMMI CBNM Webinar: Wednesday, January 28 at 12:00 pm ET This webinar provides an introductory, high-level overview of the financial and billing requirements, emphasizing coding, billing, and payment rates. Register here: snmmi.org/iCore/Events...

70% of all cancer patients are now living past the 5-year survival mark -- the highest percentage ever. Advancements in nuclear medicine - particularly in theranostics - are driving this dramatic improvement in patient outcomes. Read more: www.washingtonpost.com/health/2026/...

New year, new JNM! If you have a resolution to read more scientific articles, good news: the new issue of JNM is out now. Take a look at the highlights 👇🧵

According to one of our guests, 2025 was the biggest year in nuclear medicine...yet. Before we pop the champagne and ring in 2026, join us for one last 2025 episode of the JNM Podcast, where our guests share their highlights for the year. Tune in wherever you stream podcasts! youtu.be/Kxibmu8tRaE

The SNMMI-CTN joins ARTnet and EARL in endorsing a unified PET/CT and PET/MR scanner accreditation framework to standardize and harmonize quantitative PET imaging worldwide. Read more about this landmark effort here:

Data tells us that nuclear medicine has made extraordinary strides in curing prostate cancer, especially with the use of PSMA PET. But how are we reporting on and standardizing this data? SPARC could be the answer! The newest JNM podcast is out: youtu.be/MOkGjJtKJY0

Calling all neurologists and those interested in neurology and nuclear medicine! Don’t miss this rare opportunity to engage with the leading experts in these fields at the SNMMI Mid-Winter Meeting. Tune in and register: youtu.be/ro48nksmUFA?...

Big news for breast imaging and nuclear medicine! A new study has demonstrated that metabolic change assessed by FDG-PET/CT accurately predicted progression-free survival as early as 12 weeks after treatment initiation. More here: ecog-acrin.org/press-releas...

New in JNMT: As nuclear medicine theranostics expands rapidly across clinical practice worldwide, a new supplement explores how nuclear medicine technologists are embracing their growing role within the field. Learn more and read it here: snmmi.org/Web/News/Art...

What happens when 131I treatment stops working Some patients with recurring or metastatic differentiated thyroid cancer (DTC) stop responding to this treatment. This first-in-human study used alpha-emitters to treat refractory patients. jnm.snmjournals.org/content/earl...

The holidays must be here early, because the newest issue of The Journal of Nuclear Medicine is out now! Check out the highlights as our gift to you: jnm.snmjournals.org/content/66/12

Being able to personalize a patient's treatment is one of the cornerstones of nuclear medicine, but how are we able to do that? PET-Guided radiotherapy is one answer. Learn more about when to use it in Episode 14 of the JNM Podcast: youtu.be/J1mwyxSfitU

Pre-treating a tumor before delivering alpha-radioimmunotherapy has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer. jnm.snmjournals.org/content/earl...

It's November — the season of giving thanks — for a new issue of JNM! Here's what's inside this month: 🧵👇 jnm.snmjournals.org

Have you been hearing about Pluvicto in the news? Our patient accounts share more about what it is and how it works:

A new approach to PET #imaging published by @snm-mi.bsky.social offers a promising way for physicians to identify patients at risk for poor functional recovery after a #heartattack. #nuclearmedicine

Heart attacks affect nearly one million Americans each year, but what happens after—the healing process—is less well understood. A new PET imaging technique has changed that. Read more in this month’s JNM: jnm.snmjournals.org/content/earl...

🚀 Don’t Miss Your Chance to Apply! The Alavi Mars Shot Research Awards through SNMMI offer 5 grants of $110,000 each to advance infection & inflammation imaging. Apply by Oct 30, 2025! sites.snmmi.org/MarsShot/?_z...

Today for Nuclear Medicine Week, we wanted to give a special shoutout to the 326 nuclear pharmacists who are key in the advancement of our field - particularly for increased access to theranostics. Thank you for your vital contributions!

From atoms to AI-provided answers? The SNMMI AI Task Force is exploring how artificial intelligence can help physician workflow. What task would you give to AI for more patient face time? Let us know 👇

Happy Nuclear Medicine Week! Nuclear medicine is transforming the way we understand, diagnose, and treat disease. This year's theme -- "From Atoms to Answers" -- celebrates the members of this field from the lab to patients' bedsides. snmmi.org/Web/News/Art...

Join Us in Celebrating Nuclear Medicine Week! It's time to recognize all the hard work this community does. Join us by sharing your stories, photos, and videos of your work and celebrations!

Not in the mood for scary stories this spooky season? That's ok, because the October issue of JNM is here instead! Grab your favorite fall drink, curl up by the fire, and dig into some new research: jnm.snmjournals.org/content/66/10

A new PET tracer provides insight into how spinal cord injuries affect both the spinal cord and the brain. This new tracer identifies synapse loss, providing molecularly unique and complementary information to other imaging methods. Read more: jnm.snmjournals.org/content/66/9...

Nine Takeaways from New Guidelines on PET Myocardial Perfusion Imaging www.diagnosticimaging.com/view/nine-ta... #radiology #RadRes #NuclearMedicine

Early and accurate diagnosis of coronary artery disease is critical for improved patient outcomes. @asnc.bsky.social, @eanm.org, ACNM, and SNMMI have developed new guidelines for 18F-flurpiridaz PET myocardial perfusion imaging (MPI) and blood flow quantitation. snmmi.org/Web/News/Art...

For the first time ever, a rare malignant tumor responds to treatment. Read more below, and check out the full article in this month's @journalofnucmed.bsky.social: jnm.snmjournals.org/content/66/9...

SNMMI presented a Joint Symposium at the American Thyroid Association Annual Meeting on September 12. Drs. Mehdi Djekidel (far left) & Seza Gulec (far right) along with ATA members held a panel discussion on best practices related to radioactive iodine treatment of thyroid cancer

Two molecular targets have emerged as promising candidates for the diagnosis and treatment of endometrial cancer: Human epidermal growth factor 2 (HER2) and cluster of differentiation 24 (CD24). jnm.snmjournals.org/content/earl...

Happy September! Whether you're already missing summer or are ready for fall, JNM is always in season. Here are this month's highlights: jnm.snmjournals.org/content/66/9

New in Uptake: PET Amyloid Quantitation Methods for Degree of Amyloid Burden Explore how Z-Scores, Standardized Uptake Value Ratios, and Centiloid Scaling are used. Learn more with our infographic below, or read the full article on our website: snmmi.org/Web/News/Art...

A 5-minute Basal Cell Carcinoma diagnosis is within our reach. A topical fluorescent molecular contrast agent called PARPi-FL can detect basal cell carcinoma through intact skin in as little as 5 minutes in ex vivo human tissue. 🧵👇https://jnm.snmjournals.org/content/66/8/1197

NEW from @journalofnucmed.bsky.social: Men with biochemically resistant prostate cancer who undergo PSMA PET/CT before salvage radiotherapy have improved survival rates over those who do not. Read more here 👇🧵 jnm.snmjournals.org/content/66/8...

SNMMI is proud to launch the Global Radiopharmaceutical Trials Finder. With the help of AI, SNMMI is addressing that gap, bringing nuclear medicine care to your fingertips. Start by answering 2 easy questions: disease area and zip code: snmmi.org/Web/News/Art...

Congratulations David Gilmore, Ed.D., CNMT, RT(R)(N) on receiving the 2025 SNMMI-TS Lifetime Achievement Award for Transformative Contributions to Nuclear Medicine Technology. Read more about his work here: snmmi.org/Web/News/Art...

Summer may be winding down but the @journalofnucmed.bsky.social is hot off the presses! Check out these highlights: 🧵👇 jnm.snmjournals.org/content/66/8